NCT00001893View on ClinicalTrials.gov

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 17, 1999

Primary Completion Date

December 31, 2002

Conditions
Asthma
Interventions
DRUG

TNFR:Fc

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001893 - Study of TNFR:Fc (Enbrel) in the Treatment of Asthma | Biotech Hunter | Biotech Hunter